# FDA WARNING_LETTER - Glenmark Pharmaceuticals Limited - April 20, 2019

Source: https://www.globalkeysolutions.net/records/warning_letter/glenmark-pharmaceuticals-limited/564e19c0-f3be-4691-97d4-7b89ca5fceb2

> FDA WARNING_LETTER for Glenmark Pharmaceuticals Limited on April 20, 2019. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: Glenmark Pharmaceuticals Limited
- Inspection Date: 2019-04-20
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [483 - 2017-11-11](https://www.globalkeysolutions.net/records/483/glenmark-pharmaceuticals-limited/da1521e9-2291-4a93-9ea2-3fdff9b7facf)
- [WARNING_LETTER - 2022-05-20](https://www.globalkeysolutions.net/records/warning_letter/glenmark-pharmaceuticals-limited/0ac1907c-5a77-4f23-8229-957f8b7079ca)

## Related Officers

- [Director](https://www.globalkeysolutions.net/people/francis-godwin/1556d203-d47c-4744-af37-2591a163149e)

Company: https://www.globalkeysolutions.net/companies/glenmark-pharmaceuticals-limited/66c964bb-f670-493b-ab86-aa8507e68a5d

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c